UCART22

May 04, 2026 — Cellectis Inc. (Euronext Growth: ALCLS; Nasdaq: CLLS) announced it will report its first-quarter 2026 financial results (for the period ended March 31, 2026) on Monday, May 11, 2026, after the close of the U.S. market. The company said the earnings press release will be posted in the Investors section of its website.

Cellectis will not host a conference call for these results; investor questions will be handled via its investor relations contact email.

Business significance: The announcement provides investors with the timing and access point for near-term financial updates, but offers no operational or clinical data and no accompanying management discussion via webcast/call.